146 related articles for article (PubMed ID: 34952885)
1. Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study.
Markby J; Shilton S; Sem X; Chan HK; Md Said R; Siva S; Zainuddin Z; Abu Bakar N; Omar H; Ruiz RJI; Gaeddert M; Tyshkovskiy A; Adee M; Chhatwal J; Kumar S; Piedagnel JM; Mohd Zain R; Menétrey C; Yuswan F; Hairizan Nasir N; Andrieux-Meyer I; Ismail F; Zakaria R; Hasim R; Murad S; Easterbrook P; Hassan MRA
BMJ Open; 2021 Dec; 11(12):e055142. PubMed ID: 34952885
[TBL] [Abstract][Full Text] [Related]
2. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.
Oru E; Trickey A; Shirali R; Kanters S; Easterbrook P
Lancet Glob Health; 2021 Apr; 9(4):e431-e445. PubMed ID: 33639097
[TBL] [Abstract][Full Text] [Related]
3. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
[TBL] [Abstract][Full Text] [Related]
4. A quasi-randomised controlled trial of online distribution of home-based hepatitis C self-testing for key populations in Malaysia: a study protocol.
Shilton S; Sem X; Chan HK; Chung HY; Karunanithy A; Markby J; Chan PL; Luhmann N; Johnson C; Nabeta P; Nasir NHB; Ongarello S; Reipold EI; Hassan MRA
Trials; 2022 Apr; 23(1):304. PubMed ID: 35413933
[TBL] [Abstract][Full Text] [Related]
5. Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial.
Wade AJ; Doyle JS; Gane E; Stedman C; Draper B; Iser D; Roberts SK; Kemp W; Petrie D; Scott N; Higgs P; Agius PA; Roney J; Stothers L; Thompson AJ; Hellard ME
Trials; 2018 Jul; 19(1):383. PubMed ID: 30012192
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges.
Jacka BP; Bazerman LB; Dickerson C; Moody M; Martin J; Patry E; Cady T; Compere H; Boudreau M; Beckwith CG
Int J Drug Policy; 2022 May; 103():103668. PubMed ID: 35367903
[TBL] [Abstract][Full Text] [Related]
8. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
9. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.
Draper BL; Htay H; Pedrana A; Yee WL; Howell J; Pyone Kyi K; Naing W; Sanda Aung K; Markby J; Easterbrook P; Bowring A; Aung W; Sein YY; Nwe N; Myint KT; Shilton S; Hellard M
Liver Int; 2021 Nov; 41(11):2578-2589. PubMed ID: 34153155
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
Roberts K; Macleod J; Metcalfe C; Hollingworth W; Williams J; Muir P; Vickerman P; Clement C; Gordon F; Irving W; Waldron CA; North P; Moore P; Simmons R; Miners A; Horwood J; Hickman M
BMJ; 2020 Feb; 368():m322. PubMed ID: 32102782
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments.
Radley A; Robinson E; Aspinall EJ; Angus K; Tan L; Dillon JF
BMC Health Serv Res; 2019 Oct; 19(1):765. PubMed ID: 31660966
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
[TBL] [Abstract][Full Text] [Related]
16. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Tsertsvadze T; Gamkrelidze A; Chkhartishvili N; Abutidze A; Sharvadze L; Kerashvili V; Butsashvili M; Metreveli D; Gvinjilia L; Shadaker S; Nasrullah M; Adamia E; Zeuzem S; Afdhal N; Arora S; Thornton K; Skaggs B; Kuchuloria T; Lagvilava M; Sergeenko D; Averhoff F
Clin Infect Dis; 2020 Aug; 71(5):1263-1268. PubMed ID: 31563938
[TBL] [Abstract][Full Text] [Related]
17. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
Lebovics E; Torres R; Porter LK
Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
[TBL] [Abstract][Full Text] [Related]
18. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
19. Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.
Kamali I; Shumbusho F; Barnhart DA; Nyirahabihirwe F; Gakuru JP; Dusingizimana W; Nizeyumuremyi E; Habinshuti P; Walker S; Makuza JD; Serumondo J; Nshogoza Rwibasira G; Ndahimana JD
BMC Infect Dis; 2022 Mar; 22(1):272. PubMed ID: 35313817
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.
Kapadia SN; Marks KM
Clin Ther; 2018 Aug; 40(8):1234-1245. PubMed ID: 29983266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
